The genome-wide association study (GWAS) associated several BARD1 variants with susceptibility to high-risk neuroblastoma [44], mainly rs6435862 T>G was related with overexpression of BARD1 β [5]. This evidence concerns the gene BARD1 and neuroblastoma.